Dacoplice 40mg x30 Tablets
₦2,000,000.00
Introduction to Dacoplice 45mg Tablet
Dacoplice 45mg tablet contains the active substance Dacomitinib. It is an antineoplastic drug that belongs to the class tyrosine kinase inhibitor. It is used as a first-line treatment in adults with a type of lung cancer called non-small cell lung cancer which has spread to other parts of the body, and if a test has shown that your cancer has certain changes in a gene called EGFR (epidermal growth factor receptor).
Do not take Dacoplice 45mg tablet if you are allergic to dacomitinib or any other ingredients of this medicine. Before initiating the treatment, inform your physician if you have any other lung problems because some lung problems may get worse during treatment with this medicine. Report to your doctor immediately if you develop diarrhoea, skin rash, or symptoms of jaundice, including yellowing of your skin and eyes, dark or brown urine, and light-coloured bowel movements.
Dacoplice 45mg Tablet is not indicated in children or adolescents under the age of 18 years. Inform your physician if you have any heart disease, liver disorder, or kidney problems before initiating the treatment. The most common side effects are skin rash, changes in nails, inflamed sore mouth, decreased appetite, dry skin, decreased weight, hair loss, cough, and severe itching of the skin. This medicine is not recommended for pregnant and breastfeeding women.
Very secure payment methods
Shipping will be calculated on checkout
Please note that price may increase due to exchange rate, ensure updated price before making payment